熊谷 聡 (クマガイ サトシ)

KUMAGAI Satoshi

写真a

所属

附属病院  中央放射線部 

研究分野・キーワード

放射線医学、放射線腫瘍学、小線源治療、体幹部定位照射、インターベンショナルラジオロジー

出身大学 【 表示 / 非表示

  • 2008年04月
    -
    2015年03月

    秋田大学   医学部   医学科   卒業

出身大学院 【 表示 / 非表示

  • 2019年04月
    -
    2022年03月

    秋田大学  医学系研究科  医学専攻  博士課程  修了

取得学位 【 表示 / 非表示

  • 秋田大学 -  博士(医学)

職務経歴(学内) 【 表示 / 非表示

  • 2022年05月
    -
    継続中

    秋田大学   附属病院   中央放射線部   助教  

 

学位論文 【 表示 / 非表示

  • Safety and Treatment Outcomes of Stereotactic Body Radiotherapy for Pulmonary Tumors : A Retrospective Single-Center Study

    Satoshi Kumagai, Yuki Wada, Akira Anbai, Noriko Takagi, Eriko Okuyama, Manabu Hashimoto

    秋田医学  48 ( 3-4 ) 85 - 98   2022年03月  [査読有り]

    国内共著

    Stereotactic body radiotherapy (SBRT) uses hypofractionated and more precise irradiation methods, and has the advantages of shorter duration, better outcomes, and fewer side effects than conventional radiotherapy. However, the optimal dosage remains unclear. The purpose of the study was to analyze our preliminary treatment results and safety. We retrospectively analyzed 32 patients (primary cancer, 22; metastatic cancer, 10) who underwent SBRT for pulmonary tumors at our hospital from April 2015 to June 2020. SBRT was performed with escalated dose prescriptions (up to 55Gy in 4 fractions/64Gy in 8 fractions for peripheral/central lesions, respectively). We evaluated the local control rate (LC rate), overall survival (OS), progression-free survival (PFS), disease-specific survival (DSS), and adverse events. The target lesions comprised 22 primary lung cancers and 13 metastatic lung cancers. The 2-year LC, OS, PFS, and DSS rates were 82.5%, 68.3%, 50.5%, and 88.0% for primary lung cancer patients and 83.1%, 29.9%, 23.1%, and 48.6% for metastatic lung cancer patients, respectively. Five cases of radiation pneumonitis of grade 2 or higher, one of grade 1 dermatitis and 1 of esophagitis were observed as adverse events. We showed that the treatment outcomes of SBRT for primary and metastatic lung cancers were mostly acceptable.

MISC(査読の無い研究業績) 【 表示 / 非表示